Growth Metrics

Conmed (CNMD) Long-Term Deferred Tax (2016 - 2025)

Conmed filings provide 16 years of Long-Term Deferred Tax readings, the most recent being $13.3 million for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 20.24% to $13.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.3 million, a 20.24% increase, with the full-year FY2025 number at $13.3 million, up 20.24% from a year prior.
  • Long-Term Deferred Tax hit $13.3 million in Q4 2025 for Conmed, up from $11.1 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $13.3 million in Q4 2025 to a low of $9.6 million in Q4 2022.
  • Median Long-Term Deferred Tax over the past 5 years was $11.1 million (2024), compared with a mean of $11.0 million.
  • Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 41.14% in 2021 and later fell 1.27% in 2024.
  • Conmed's Long-Term Deferred Tax stood at $9.7 million in 2021, then decreased by 0.07% to $9.6 million in 2022, then increased by 16.18% to $11.2 million in 2023, then dropped by 1.27% to $11.1 million in 2024, then increased by 20.24% to $13.3 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $13.3 million (Q4 2025), $11.1 million (Q4 2024), and $11.2 million (Q4 2023) per Business Quant data.